Yamashita Health Care Holdings Inc

Yamashita Health Care Holdings Inc maintains a conservative capital structure with no long-term debt and a debt-to-equity ratio of 0.0, indicating a strong liquidity position. The company's liquidity is further supported by cash and equivalents of ¥5.698 billion, which is 20.7% of total assets. The current ratio of 1.2 suggests the company can cover its short-term liabilities with its current assets, although there is limited buffer for unexpected obligations. Profitability metrics show a return on equity (ROE) of 6.86% and a return on assets (ROA) of 2.24%, both below the industry median for Medical Equipment, Supplies & Distribution. The company's operating margin is 1.35% (¥871 million operating income on ¥64.49 billion revenue), which is significantly lower than the industry median, indicating potential inefficiencies in cost management or pricing power. The company's revenue is distributed across three segments: Medical Equipment Sales, Medical Device Manufacture and Sale, and Medical Mall. The Medical Equipment Sales segment is the largest contributor, but the company's geographic exposure is concentrated in Japan, particularly in the Hiroshima Prefecture where its Medical Mall operates. This concentration increases vulnerability to regional economic or regulatory shifts. Growth trajectory appears modest, with no significant revenue growth reported in the latest period. The company's capital expenditure of ¥310 million is relatively low, suggesting a conservative approach to expansion. Analysts have recorded the last actual revenue at ¥64.49 billion, with no forward-looking guidance provided in the input data. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position mitigate credit risk, but the absence of long-term debt could limit its ability to finance growth opportunities. No dilution sources were identified in the input data, and the company's shares outstanding have not changed between basic and diluted counts. Recent events include the latest financial filing, which disclosed the company's operating cash flow of ¥618 million and free cash flow of ¥355 million. No recent earnings call transcripts or material regulatory filings were included in the input data, limiting visibility into management's strategic direction or emerging risks.